DRISTi
SHORT INTRO VIDEO
Revolutionizing Retinal Screening in minutes
Explore DRISTi (Diabetic Retinopathy Intelligent Screening Technology integrated)—our advanced tool for diabetic retinopathy screening. Powered by AI, it operates offline, ensuring accurate, accessible eye care anywhere. Watch our brief video to see how DRISTi supports healthcare providers with state-of-the-art technology in minutes. Step into the future of medical diagnostics.
![Revolutionizing Retinal Screening in minutes](/_next/image?url=%2Fimages%2Fdristi_screenshot.png&w=2048&q=75)
Using State of the Art Transformers Architecture
Comprehensive Retinal Pathology Detection
DRISTi harnesses the power of advanced AI algorithms to deliver unparalleled precision in retinal pathology detection. By accurately identifying and classifying four distinct levels of Diabetic Retinopathy (stages 0-4), DRISTi provides precise and reliable assessments, supported by explainable AI. This ensures that healthcare providers can understand and trust the AI's decision-making process.Beyond Diabetic Retinopathy, DRISTi's capabilities extend to the identification of 16 DR-related pathologies. This comprehensive detection includes various retinal abnormalities associated with diabetes, enabling early intervention and tailored treatment plans for patients. Moreover, DRISTi's sophisticated algorithms can detect 20 additional multi-pathologies, covering a wide range of retinal conditions like ARMD, Glaucoma and more. This broad detection spectrum ensures a thorough retinal health check-up, which is crucial for the early identification and management of various eye diseases. By integrating such extensive detection capabilities, DRISTi plays a vital role in facilitating early intervention, improving patient outcomes, and enhancing the overall quality of eye care.
![service](/_next/image?url=%2Fimages%2Fblog%2Ffundus_pics%2Fartelus_dr4_report.jpg&w=1920&q=75)
Glaucoma Detection
Independent Operation with Offline Capability
DRISTi is engineered for versatility and adaptability, making it an invaluable tool in diverse and challenging environments. One of its standout features is the ability to operate independently, without the need for an internet connection. This offline functionality is made possible by an integrated Compute Stick, ensuring that DRISTi delivers reliable performance even in remote or resource-limited settings. This independence from internet connectivity significantly enhances accessibility, allowing advanced diabetic retinopathy screening tools to reach underserved areas. Healthcare providers can confidently use DRISTi in rural clinics, mobile health units, and other remote locations, ensuring that patients receive critical eye care regardless of their geographic location. In addition to its robust diabetic retinopathy screening capabilities, DRISTi is also equipped to predict the Cup To Disc Ratio (CDR). This crucial measurement helps in the early detection of Glaucoma suspects, facilitating timely interventions that can prevent vision loss. By providing comprehensive eye health assessments in offline mode, DRISTi empowers healthcare professionals to deliver high-quality care and improve patient outcomes in any setting.
![service](/_next/image?url=%2Fimages%2Fblog%2Ffundus_pics%2Fartelus_dr1_report.jpg&w=1920&q=75)
Bringing Healthcare to the "Forgotten Billions"
The foundational ethos of Artelus is encapsulated in its forward-thinking vision: Leveraging state-of-the-art Deep Learning architectures to democratize healthcare for the "Forgotten Billions". At Artelus.ai, we are dedicated to advancing eye care through innovative technology and comprehensive solutions, making high-quality diagnostics accessible to all. Join us in revolutionizing healthcare and improving the lives of millions around the world.